- NYSE: AMC fell by 8.56% during Tuesday’s trading session.
- Investor Jim Chanos is using APE shares as a way of arbitraging AMC.
- Wedbush analysts lower the price target for AMC stock to $2.00.
UPDATE: AMC stock is trading down 2.4% at $9.33. If it stays in the red, this would be its sixth straight session losing ground. More than 18,000 put contracts for the $15 strike price expiring this Friday have traded in the first half hour on Wednesday. The last price was $0.96 per share, and the value of the contract is up 100% from Tuesday. AMC stock has not traded this low since May 7, 2021. On Tuesday the meme stock broke through support at $10 from May 11 and 12. There is support from February and April of 2021 near $5.50 and $8, respectively.
NYSE: AMC continued to see its common shares tumble on Tuesday, although the price of its recently released preferred shares seem to have stabilized. Shares of AMC dropped by a further 8.56% and closed the trading session at a price of $9.56. Stocks were mixed on Tuesday, as the broader markets somewhat recovered from Monday’s intense sell off. Despite what looked to be a positive start to the day, all three major indices closed in the red once again. Overall, the Dow Jones fell by 154 basis points, the S&P 500 dropped by 0.22%, and the NASDAQ traded flat for the day.
Stay up to speed with hot stocks' news!
After the interesting split that AMC recently did, famed short seller Jim Chanos is using the opportunity for some classic arbitrage. Chanos told CNBC that he believes the two securities should be trading at the same price, and will eventually do so. He has established a long position in Ape (NYSE:APE) and a short position in AMC. CEO Adam Aron has told Apes to combine the prices of the two securities to get the true stock price value of AMC shares. Shares of APE rose by 17.0% during Tuesday’s session.
AMC stock forecast
Wall Street analysts at Wedbush have downgraded their already low price target for shares of AMC. The price target was cut in half from $4.00 to $2.00 to account for the release of the APE shares. Wedbush is not impressed with the stock dilution, citing that AMC would have to issue 900 million shares of APE to repay all of its debt.
Like this article? Help us with some feedback by answering this survey:
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.
Recommended content
Editors’ Picks
EUR/USD extends gains above 1.0700, focus on key US data
EUR/USD meets fresh demand and rises toward 1.0750 in the European session on Thursday. Renewed US Dollar weakness offsets the risk-off market environment, supporting the pair ahead of the key US GDP and PCE inflation data.
USD/JPY keeps pushing higher, eyes 156.00 ahead of US GDP data
USD/JPY keeps breaking into its highest chart territory since June of 1990 early Thursday, recapturing 155.50 for the first time in 34 years as the Japanese Yen remains vulnerable, despite looming intervention risks. The focus shifts to Thursday's US GDP report and the BoJ decision on Friday.
Gold price edges higher amid weaker USD and softer risk tone, focus remains on US GDP
Gold price (XAU/USD) attracts some dip-buying in the vicinity of the $2,300 mark on Thursday and for now, seems to have snapped a three-day losing streak, though the upside potential seems limited.
Injective price weakness persists despite over 5.9 million INJ tokens burned
Injective price is trading with a bearish bias, stuck in the lower section of the market range. The bearish outlook abounds despite the network's deflationary efforts to pump the price.
US Q1 GDP Preview: Economic growth set to remain firm in, albeit easing from Q4
The United States Gross Domestic Product (GDP) is seen expanding at an annualized rate of 2.5% in Q1. The current resilience of the US economy bolsters the case for a soft landing.